Renal · Acute Kidney Injury
The facts most likely to be tested
Contrast-induced nephropathy is defined as an acute rise in serum creatinine of ≥0.3 mg/dL or ≥50% from baseline within 48 to 72 hours of intravascular contrast administration.
The most significant risk factor for developing contrast-induced nephropathy is pre-existing chronic kidney disease, particularly with an estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m².
Intravenous isotonic saline (0.9% NaCl) is the only proven prophylactic measure to reduce the incidence of contrast-induced nephropathy by ensuring adequate volume expansion.
N-acetylcysteine and sodium bicarbonate are no longer recommended for routine prophylaxis as they lack consistent evidence of clinical benefit in preventing contrast-induced nephropathy.
The risk of contrast-induced nephropathy is significantly higher with intra-arterial administration of contrast compared to intravenous administration due to higher local concentrations reaching the renal arteries.
Patients with diabetes mellitus are at increased risk for contrast-induced nephropathy, especially when combined with underlying renal insufficiency.
Contrast-induced nephropathy typically presents as a non-oliguric form of acute tubular necrosis that is usually transient and resolves within 1 to 2 weeks.
Vignette unlocked
A 68-year-old male with a history of type 2 diabetes and stage 4 chronic kidney disease (baseline creatinine 2.4 mg/dL) undergoes an emergent coronary angiography for suspected NSTEMI. He receives 150 mL of low-osmolar iodinated contrast during the procedure. Forty-eight hours later, his serum creatinine rises to 3.1 mg/dL. He is currently asymptomatic and maintains a normal urine output.
What is the most likely diagnosis?
Contrast-induced nephropathy
The patient meets the diagnostic criteria of a >0.3 mg/dL rise in creatinine within 48 hours of contrast exposure in the setting of high-risk pre-existing renal disease, consistent with the definition provided in the first bet.
Full handout
High yield triage
Etiology / Epidemiology
Occurs in patients with pre-existing CKD (eGFR <60) or diabetes mellitus following intravascular iodinated contrast administration.
Clinical Manifestations
Typically asymptomatic rise in serum creatinine peaking within 3-5 days; non-oliguric renal failure is common.
Diagnosis
Defined as a ≥25% increase or ≥0.5 mg/dL absolute rise in serum creatinine within 48-72 hours of exposure.
Treatment
Prevention is key: intravenous isotonic saline (0.9% NaCl) is the only proven therapy; avoid loop diuretics.
Prognosis
Most cases are transient and reversible; however, severe cases may require hemodialysis in patients with baseline advanced CKD.
Full handout
Epidemiology & Etiology
Risk is highest in patients with pre-existing renal insufficiency (eGFR <60 mL/min/1.73m²) and diabetic nephropathy. Other significant risk factors include hypovolemia, congestive heart failure, and the use of high-osmolar contrast media. The risk is negligible in patients with normal renal function.
Pertinent Anatomy
The renal medulla is the primary site of injury due to its relatively low oxygen tension and high metabolic demand. Contrast agents cause direct tubular toxicity and localized vasoconstriction in the vasa recta.
Pathophysiology
Contrast media induce medullary hypoxia through a combination of direct tubular epithelial cell toxicity and reactive oxygen species generation. Concurrently, contrast causes afferent arteriolar vasoconstriction, reducing glomerular filtration rate. This leads to a state of acute tubular necrosis (ATN) that is typically non-oliguric.
Clinical Manifestations
Patients are usually asymptomatic and identified only via routine laboratory monitoring. Red flags include sudden oliguria or signs of volume overload (e.g., pulmonary edema) if the patient has underlying heart failure. The clinical course is characterized by a non-oliguric rise in creatinine that peaks at 3-5 days and returns to baseline within 1-2 weeks.
Diagnosis
Diagnosis is a clinical exclusion based on the serum creatinine rise of ≥25% or ≥0.5 mg/dL within 48-72 hours post-contrast. Urinalysis typically shows muddy brown casts consistent with ATN. No specific imaging is required for diagnosis; it is a diagnosis of exclusion after ruling out other causes of acute kidney injury.
Treatment
The first-line intervention is intravenous isotonic saline (0.9% NaCl) for volume expansion before and after the procedure. Avoid loop diuretics and NSAIDs as they exacerbate renal hypoperfusion. If the patient is on metformin, it should be held if eGFR is <30 to prevent lactic acidosis in the event of renal failure.
Prognosis
The condition is generally self-limiting with renal function returning to baseline in 7-14 days. Key complications include the rare need for temporary hemodialysis in patients with severe baseline CKD. Long-term outcomes are primarily dictated by the severity of the patient's underlying chronic kidney disease.
Differential Diagnosis
Atheroembolic disease: presence of livedo reticularis or blue toe syndrome
Acute interstitial nephritis: presence of eosinophiluria and rash
Prerenal azotemia: BUN/Cr ratio >20:1 and response to fluid challenge
Post-renal obstruction: hydronephrosis on renal ultrasound
Aminoglycoside toxicity: history of prolonged antibiotic exposure